Massive Pulmonary Embolism: Trial of Non-immunogenic Recombinant Staphylokinase VS Alteplase FORPE
Clinical trial NCT04688320 · COMPLETED
Trial details
- NCT number
- NCT04688320
- Sponsor
- Supergene, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-15
- Primary completion
- 2023-07-27
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.